Status:
UNKNOWN
Prospective Multicenter Nationwide Registry of Children With Eosinophilic Esophagitis
Lead Sponsor:
Sociedad Espanola de Gastroenterologia, Hepatologia y Nutricion Pediatrica
Conditions:
Eosinophilic Esophagitis
Eligibility:
All Genders
1-18 years
Brief Summary
1. Registry of demographic, clinical, endoscopic and histological data at baseline. 2. Registry of patients treated with PPI: * Clinical, endoscopic and histological response at 8-12 weeks of indu...
Eligibility Criteria
Inclusion
- Children from 1 month to 18 years with a new diagnosis of eosinophilic esophagitis (EoE) according to the recent European guidelines (symptoms of esophageal dysfunction + eosinophilic infiltrate of the esophagus \> 15 eos / CGA)
- And that they need to start treatment with any of the following options: PPI, diet excluding cow's milk and gluten, or swallowed corticosteroids .
Exclusion
- Presence of pathological eosinophilia at the gastric or duodenal level (eosinophilic gastroenteritis)
- Simultaneous treatment with more than one treatment modality (PPI, empirical elimination diet, swallowed corticosteroids).
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03858426
Start Date
January 1 2019
End Date
July 30 2022
Last Update
February 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Puerta de Hierro Majadahonda
Madrid, Spain, 28222